{"id":223637,"date":"2025-10-19T00:04:27","date_gmt":"2025-10-19T05:04:27","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/10\/blood-test-can-detect-more-than-50-kinds-of-cancer-new-study-suggests"},"modified":"2025-10-19T00:04:27","modified_gmt":"2025-10-19T05:04:27","slug":"blood-test-can-detect-more-than-50-kinds-of-cancer-new-study-suggests","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/10\/blood-test-can-detect-more-than-50-kinds-of-cancer-new-study-suggests","title":{"rendered":"Blood test can detect more than 50 kinds of cancer, new study suggests"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/blood-test-can-detect-more-than-50-kinds-of-cancer-new-study-suggests.jpg\"><\/a><\/p>\n<p>Made by U.S. pharmaceutical company Grail, the Galleri test aims to find fragments of DNA in a person\u2019s blood that can indicate the presence of a cancerous tumor. Among the cancers that the test can detect, many have no current screening programs.<\/p>\n<p>The PATHFINDER 2 study included more than 36,000 people aged 50 and older who had no cancer symptoms. In participants who were followed for more than a year, the test caught some 40.4% of cancer cases. For those who got a positive result on the Galleri test, 61.6% of them went on to be diagnosed with cancer\u2014an improvement over previous trials of the test.<\/p>\n<p>The results were presented on Saturday at the European Society for Medical Oncology meeting in Berlin, and have yet to be published in a peer-reviewed journal.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Made by U.S. pharmaceutical company Grail, the Galleri test aims to find fragments of DNA in a person\u2019s blood that can indicate the presence of a cancerous tumor. Among the cancers that the test can detect, many have no current screening programs. The PATHFINDER 2 study included more than 36,000 people aged 50 and older [\u2026]<\/p>\n","protected":false},"author":599,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-223637","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/223637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/599"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=223637"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/223637\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=223637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=223637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=223637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}